Plant Comparison
Borage vs Bitter Melon
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Borage and Bitter Melon: they share 6 indicated uses (arthritis / joint pain, bloating, cancer (anticancer research), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Borage | Bitter Melon | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Bitter Melon |
| Bloating | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 9/10 | Stronger for Bitter Melon |
| Indigestion | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Borage seed oil has one of the highest known GLA contents of any plant oil (typically 20-26%), the basis of its anti-inflammatory reputation.
Unsaturated pyrrolizidine alkaloids present in the whole herb are hepatotoxic and genotoxic on cumulative exposure, limiting internal whole-herb use; the refined seed oil is largely free of them.
Contribute to the plant's traditional demulcent and astringent properties.
Now regarded as the main antidiabetic principles.
A mixture of two sterol glucosides, historically credited with the hypoglycaemic effect.
An insulin-like polypeptide of the fruit and seed.
A pyrimidine glycoside that can trigger favism in G6PD-deficient people.
Pharmacological Actions
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from immunomodulator action
inferred from digestive action
inferred from anti-inflammatory action
inferred from bitter-tonic action
inferred from anti-inflammatory action
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Pyrrolizidine alkaloids (PAs): Many Boraginaceae can produce PAs; unsaturated PAs are hepatotoxic and genotoxic (risk increases with cumulative exposure). Borage as food/tea: PA presence in borage consumed as herb/tea has been specifically studied; EU has set PA maximum levels for certain foods including borage (context for why sourcing/limits matter). Pregnancy/breastfeeding: avoid internal use of borage herb products due to PA-related concerns and risk uncertainty. Liver disease / long-term use: avoid (PA risk + cumulative exposure logic). Seed oil vs herb: refined/quality-controlled seed oil is generally the preferred form when borage is used medicinally, because the main target compound is GLA; however, product quality and contamination control still matter. Drug interactions (caution): GLA oils have been discussed with anticoagulants (bleeding risk caution is better established for evening primrose oil; borage oil is often grouped in the same “GLA oil” category). Use caution if on anticoagulants/antiplatelets.
Duke (2002) rates borage as a single-plus herb (+) with predominantly folklore-level evidence. Borage seed oil is rich in gamma-linolenic acid (GLA) and has been used for inflammatory conditions such as arthritis and PMS, and for cardiovascular support; typical dose is one 300 mg softgel containing 24% GLA or 2-4 ml liquid leaf extract. Commission E does not approve borage for any indication, and the herb contains hepatotoxic and carcinogenic pyrrolizidine alkaloids, making long-term use inadvisable (Duke, 2002).
Avoid in pregnancy: bitter melon can stimulate the uterus and has been associated with miscarriage; also avoid during breastfeeding.
Strong blood-sugar-lowering action: used with insulin or other diabetes medicines it can cause hypoglycaemia - monitor blood glucose and seek medical advice.
People with glucose-6-phosphate dehydrogenase (G6PD) deficiency should avoid the seeds, which contain vicine and can cause favism (haemolytic anaemia). Excessive intake may cause abdominal pain and diarrhoea.
External Ids
Botanical Description
Robust, bristly annual herb with hollow, branching stems covered in coarse, stiff hairs. The leaves are large, oval and wrinkled, also coarsely hairy, and smell of cucumber when crushed. The flowers are strikingly bright blue, star-shaped with five pointed petals and a prominent black central cone of anthers, borne in nodding clusters.[1]
Climbing or trailing annual vine (Cucurbitaceae) that climbs by simple tendrils, typically 2-5 m long. Leaves are alternate, long-stalked and palmately lobed with 5-7 deep, toothed lobes. Flowers are small, yellow and five-petalled, male and female flowers separate on the same plant. The fruit is an oblong, warty-skinned gourd that ripens from green to orange-yellow and splits open to reveal seeds coated in a bright red aril; the unripe green fruit is the part used medicinally and as food.
Habitat
Grows readily on disturbed, nutrient-rich ground, gardens, waste places and field margins; native to the Mediterranean region and widely naturalised and cultivated across Europe and elsewhere as a culinary and oil-seed crop.[1]
Likely native to tropical Asia (possibly the Indian subcontinent), now widely cultivated across tropical and subtropical Asia, Africa, the Caribbean and increasingly the Americas as a vegetable and medicinal crop; needs warmth, full sun and a trellis or support to climb.[11]
Harvesting
Leaves and flowers are picked fresh through the growing season, at their best just as the flowers open; the seed is collected in late summer once the seed heads have dried, pressed for its gamma-linolenic-acid-rich oil.[1]
The fruit is harvested unripe, while still green and firm, before it yellows and splits, for use as a vegetable and in traditional antidiabetic preparations; leaves are also traditionally gathered.[11]
Traditional Uses
Borage has a long folk reputation, reflected in the old saying 'borage for courage', as a mood-lifting, cooling herb for feverish colds and respiratory complaints, and as a digestive and anti-inflammatory remedy; the fresh leaves and flowers have also been used culinarily. Modern use is centred on the seed oil, rich in gamma-linolenic acid (GLA), for inflammatory and skin conditions.[1]
Bitter melon has a long history in Asian, African and Caribbean traditional medicine as a bitter digestive tonic and mild laxative, and most notably as a remedy for diabetes and its complications; this traditional antidiabetic use is now the most scientifically supported of its properties, with numerous studies on its blood-glucose- and lipid-lowering effects.[4, 11]
Preparations
Dosage
A phase-two randomised placebo-controlled trial in moderate persistent asthma used Borago officinalis extract at 5 mL three times daily for one month. Because of pyrrolizidine alkaloid content, whole-herb (leaf/flower) preparations should only be used short-term and from PA-controlled sources; avoid in pregnancy, breastfeeding and liver disease. Educational reference only, not a prescription.
Clinical trials studying bitter melon for blood-sugar support have used standardised fruit extract or juice preparations taken daily over several weeks; dosing varies by product. Because it can lower blood glucose, monitor levels closely if combining with diabetes medication. Educational reference only, not a prescription.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
Drug Class Interactions
Not documented
References & Sources
- Slama, M., Slougui, N., Benaissa, A., Nekkaa, A. et al (2024) 'Borago officinalis L.: A Review on Extraction, Phytochemical, and Pharmacological Activities', Chemistry & Biodiversity, 21(5), pp. e202301822. doi:10.1002/cbdv.202301822 Traditional / reference
https://doi.org/10.1002/cbdv.202301822 - Michalak, M., Zagórska-Dziok, M., Klimek-Szczykutowicz, M. and Szopa, A (2023) 'Phenolic Profile and Comparison of the Antioxidant, Anti-Ageing, Anti-Inflammatory, and Protective Activities of Borago officinalis Extracts on Skin Cells', Molecules, 28(2), pp. 868. doi:10.3390/molecules28020868 Preclinical
https://doi.org/10.3390/molecules28020868 - Ghasemian, M., Owlia, S. and Owlia, M.B (2016) 'Review of Anti-Inflammatory Herbal Medicines', Advances in Pharmacological Sciences, 2016, pp. 9130979. doi:10.1155/2016/9130979 Traditional / reference
https://doi.org/10.1155/2016/9130979 - Di Cerbo, A., Carnevale, G., Avallone, R., Zavatti, M. and Corsi, L (2020) 'Protective Effects of Borago officinalis (Borago) on Cold Restraint Stress-Induced Gastric Ulcers in Rats: A Pilot Study', Frontiers in Veterinary Science, 7, pp. 427. doi:10.3389/fvets.2020.00427 Preclinical
https://doi.org/10.3389/fvets.2020.00427 - Seo, S.A., Park, B., Hwang, E., Park, S. and Yi, T (2018) 'Borago officinalis L. attenuates UVB-induced skin photodamage via regulation of AP-1 and Nrf2/ARE pathway in normal human dermal fibroblasts and promotion of collagen synthesis in hairless mice', Experimental Gerontology, 107, pp. 178-186. doi:10.1016/j.exger.2018.02.017 Preclinical
https://doi.org/10.1016/j.exger.2018.02.017 - Mirsadraee, M., Khashkhashi Moghaddam, S., Saeedi, P. and Ghaffari, S (2016) 'Effect of Borago Officinalis Extract on Moderate Persistent Asthma: A Phase two Randomized, Double Blind, Placebo-Controlled Clinical Trial', Tanaffos, 15(3), pp. 168-174. doi:10.1183/13993003.congress-2016.pa4116 Randomized trial
https://doi.org/10.1183/13993003.congress-2016.pa4116 - Lozano-Baena, M., Tasset, I., Munoz-Serrano, A., Alonso-Moraga, A. and de Haro-Bailon, A (2016) 'Cancer Prevention and Health Benefices of Traditionally Consumed Borago officinalis Plants', Nutrients, 8(1), pp. 48. doi:10.3390/nu8010048 Preclinical
https://doi.org/10.3390/nu8010048 - Rodriguez-Magana, M.P., Cordero-Perez, P., Rivas-Morales, C., Oranday-Cardenas, M.A., Moreno-Pena, D.P., Garcia-Hernandez, D.G. and Leos-Rivas, C (2019) 'Hypoglycemic Activity of Tilia americana, Borago officinalis, Chenopodium nuttalliae, and Piper sanctum on Wistar Rats', Journal of Diabetes Research, 2019, pp. 7836820. doi:10.1155/2019/7836820 Preclinical
https://doi.org/10.1155/2019/7836820 - Navarro-Herrera, D., Aranaz, P., Eder-Azanza, L., Zabala, M., Romo-Hualde, A., Hurtado, C., Calavia, D., Lopez-Yoldi, M., Martinez, J.A., Gonzalez-Navarro, C.J. and Vizmanos, J.L (2018) 'Borago officinalis seed oil (BSO), a natural source of omega-6 fatty acids, attenuates fat accumulation by activating peroxisomal beta-oxidation both in C. elegans and in diet-induced obese rats', Food & Function, 9(8), pp. 4340-4351. doi:10.1039/c8fo00423d Preclinical
https://doi.org/10.1039/c8fo00423d - Moliner, C., Casedas, G., Barros, L., Finimundy, T.C., Gomez-Rincon, C. and Lopez, V (2022) 'Neuroprotective Profile of Edible Flowers of Borage (Borago officinalis L.) in Two Different Models: Caenorhabditis elegans and Neuro-2a Cells', Antioxidants, 11(7), pp. 1244. doi:10.3390/antiox11071244 Preclinical
https://doi.org/10.3390/antiox11071244 - Samy, M.N., Hamed, A.N.E., Sugimoto, S., Otsuka, H., Kamel, M.S. and Matsunami, K (2015) 'Officinalioside, a new lignan glucoside from Borago officinalis L', Natural Product Research, 30(8), pp. 967-972. doi:10.1080/14786419.2015.1088540 Preclinical
https://doi.org/10.1080/14786419.2015.1088540 - Yue, Y., Jin, F. and Yue, X (2021) 'The effect of Borago officinalis on the signaling pathway of the NLRP3 inflammasome complex, TLR4 and some inflammatory cytokines in type II diabetic patients with acute respiratory distress syndrome', Cellular and Molecular Biology, 67(3), pp. 178-183. doi:10.14715/cmb/2021.67.3.28 Clinical study
https://doi.org/10.14715/cmb/2021.67.3.28 - Fernandes, L., Pereira, J.A., Saraiva, J.A., Ramalhosa, E. and Casal, S (2019) 'Phytochemical characterization of Borago officinalis L. and Centaurea cyanus L. during flower development', Food Research International, 123, pp. 771-778. doi:10.1016/j.foodres.2019.05.014 Preclinical
https://doi.org/10.1016/j.foodres.2019.05.014 - European Medicines Agency (HMPC) (2021) 'Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs), including recommendations regarding contamination of herbal medicinal products with PAs, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/public-statement/public-statement-use-herbal-medicinal-products-containing-toxic-unsaturated-pyrrolizidine-alkaloids-pas-including-recommendations-regarding-contamination-herbal-medicinal-products-pyrrolizidine_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/public-statement/public-statement-use-herbal-medicinal-products-containing-toxic-unsaturated-pyrrolizidine-alkaloids-pas-including-recommendations-regarding-contamination-herbal-medicinal-products-pyrrolizidine_en.pdf - Kapoor, R. and Huang, Y.S (2006) 'Gamma linolenic acid: an antiinflammatory omega-6 fatty acid', 7(6), pp. 531--534. doi:10.2174/138920106779116874 Traditional / reference
https://doi.org/10.2174/138920106779116874 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Negroni, M.S., Marengo, A., Caruso, D., et al (2019) 'A case report of accidental intoxication following ingestion of foxglove confused with borage: high digoxinemia without major complications', Case Reports in Cardiology, 2019, pp. 9707428. doi:10.1155/2019/9707428 Clinical study
https://doi.org/10.1155/2019/9707428 - Iraci, F. and Herdeg, C. and Holzwarth, M. and Storz, M.A (2023) 'Of mixed vegetables and cardiac arrhythmias - Digitalis purpurea confused with Borago officinalis: a case series of accidental digitoxin intoxications', Journal of Cardiology Cases, 28(2), pp. 86-90. doi:10.1016/j.jccase.2023.04.007 Clinical study
https://doi.org/10.1016/j.jccase.2023.04.007
- Kim, S.K., Jung, J., Jung, J.H., Yoon, N. and others (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Fang, E.F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V.A. and others (2019) 'Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)', Current Protein & Peptide Science, 20(3), pp. 296-301. doi:10.2174/1389203719666180622095800 Meta-analysis / review
https://doi.org/10.2174/1389203719666180622095800 - Raina, K., Kumar, D. and Agarwal, R (2016) 'Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy', Seminars in Cancer Biology, 40-41, pp. 116-129. doi:10.1016/j.semcancer.2016.07.002 Meta-analysis / review
https://doi.org/10.1016/j.semcancer.2016.07.002 - Basch, E., Gabardi, S. and Ulbricht, C (2003) 'Bitter melon (Momordica charantia): a review of efficacy and safety', American Journal of Health-System Pharmacy, 60(4), pp. 356-359. doi:10.1093/ajhp/60.4.356 Meta-analysis / review
https://doi.org/10.1093/ajhp/60.4.356 - Bora, A.F.M., Kouame, K.J.E., Li, X., Liu, L. and others (2023) 'New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review', International Journal of Biological Macromolecules, 231, pp. 123173. doi:10.1016/j.ijbiomac.2023.123173 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2023.123173 - Soo May, L., Sanip, Z., Ahmed Shokri, A., Abdul Kadir, A. and others (2018) 'The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial', Complementary Therapies in Clinical Practice, 32, pp. 181-186. doi:10.1016/j.ctcp.2018.06.012 Randomized trial
https://doi.org/10.1016/j.ctcp.2018.06.012 - Elekofehinti, O.O., Ariyo, E.O., Akinjiyan, M.O., Olayeriju, O.S. and others (2018) 'Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies', Pathophysiology, 25(4), pp. 327-333. doi:10.1016/j.pathophys.2018.05.003 Preclinical
https://doi.org/10.1016/j.pathophys.2018.05.003 - Leung, L., Birtwhistle, R., Kotecha, J., Hannah, S. and others (2009) 'Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review', British Journal of Nutrition, 102(12), pp. 1703-1708. doi:10.1017/S0007114509992054 Meta-analysis / review
https://doi.org/10.1017/S0007114509992054 - Krawinkel, M.B. and Keding, G.B (2006) 'Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia', Nutrition Reviews, 64(7 Pt 1), pp. 331-337. doi:10.1301/nr.2006.jul.331-337 Meta-analysis / review
https://doi.org/10.1301/nr.2006.jul.331-337 - Fang, E.F. and Ng, T.B (2011) 'Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties', Current Molecular Medicine, 11(5), pp. 417-436. doi:10.2174/156652411795976583 Meta-analysis / review
https://doi.org/10.2174/156652411795976583 - Cicek, S.S (2022) 'Momordica charantia L. - Diabetes-Related Bioactivities, Quality Control, and Safety Considerations', Frontiers in Pharmacology. doi:10.3389/fphar.2022.904643 Traditional / reference
https://doi.org/10.3389/fphar.2022.904643 - WebMD (n.d.) 'Bitter Melon: Overview, Uses, Side Effects, Precautions, Interactions'. Available at: https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon Traditional / reference
https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon - Yedjou, C.G., Grigsby, J., Mbemi, A., Nelson, D., Mildort, B., Latinwo, L. and Tchounwou, P.B (2023) 'The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins', International Journal of Molecular Sciences. doi:10.3390/ijms24109085 Randomized trial
https://doi.org/10.3390/ijms24109085 - Kim, S.K., Jung, J., Jung, J.H., Yoon, N., Kang, S.S., Roh, G.S. and Hahm, J.R (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.